瘤周强化在鉴别肌层浸润性与非肌层浸润性膀胱癌中的诊断意义
该回顾性研究纳入95例膀胱癌患者的多参数MRI,评估瘤周强化(PTE)在肌层浸润性膀胱癌(MIBC)与非肌层浸润性膀胱癌(NMIBC)中的出现频率,并提出将PTE纳入VI-RADS的改良诊断标准。结果显示PTE在MIBC中更常见(70-81% vs 非MIBC中92-98%缺失),改良VI-RADS的敏感度(75.0-86.1%)显著高于原VI-RADS(41.7-55.6%),特异度无统计学差异。
要点
- PTE定义为肿瘤侵犯边缘向外凸出、强化程度超过正常肌层和肿瘤的线样强化。
- PTE在MIBC中出现频率为70-81%,在NMIBC中92-98%缺失。
- 改良VI-RADS(原分类≤3时若存在PTE则升级为4)可提高MIBC诊断敏感度。
核心结论
- PTE是MIBC的高度特异性征象,将PTE纳入VI-RADS可提高MIBC的诊断敏感度。
研究设计与样本
- 回顾性研究,纳入95例膀胱癌患者(年龄72±11岁;77例男性;36例MIBC,59例NMIBC),2011年至2023年间在转诊中心接受多参数MRI,由四名放射科医生判读,以病理诊断为参考标准。
关键影像表现/征象
- PTE表现为肿瘤侵犯边缘处向外凸出、强化程度超过正常肌层和肿瘤的线样对比强化。
- PTE在MIBC中见于70-81%(25/36-29/36),在NMIBC中92-98%(54/59-58/59)缺失。
- 所有判读者中,PTE在MIBC组均显著高于NMIBC组(p < 0.001)。
诊断标准与关键数值
- 原VI-RADS诊断MIBC的敏感度为41.7-55.6%,特异度为98.3-100%。
- 改良VI-RADS(原VI-RADS分类≤3时若存在PTE则升级为4)诊断MIBC的敏感度为75.0-86.1%,特异度为91.5-98.3%。
- 改良VI-RADS敏感度显著高于原VI-RADS(p = 0.002-0.008),特异度无统计学差异。
临床应用与阅片要点
- 判读VI-RADS时注意观察肿瘤边缘是否存在向外凸出、强化超过正常肌层和肿瘤的线样强化(PTE)。
- 对于原VI-RADS分类≤3且存在PTE的病例,可考虑将最终分类升级为4。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was to assess the prevalence of peritumoral enhancement (PTE) in patients with muscle-invasive bladder cancer (MIBC) and non-MIBC (NMIBC) and to propose a modified diagnostic criterion for Vesical Imaging Reporting and Data System (VI-RADS) that incorporates PTE.
MATERIALS AND METHODS: This retrospective study included 95 patients with bladder cancer (age, 72 ± 11; 77 men; 36 MIBCs and 59 Non-MIBCs) who underwent multiparametric MRI in our referral center between 2011 and 2023. The images were interpreted by four radiologists. The readers classified the possibility of muscle layer invasion into categories 1-5, based on the VI-RADS categorical diagnostic criterion. PTE was defined as a linear contrast enhancement observed at the edge of tumor invasion which is convex outward from the normal bladder wall and contrasts more than the normal muscle layer and tumor. A modified VI-RADS that upgrades the final VI-RADS category to 4 if PTE is present when the original VI-RADS category is 3 or less was proposed. The frequency of PTE in the MIBC and NMIBC groups was compared using the Fisher's exact test. Sensitivity and specificity for the diagnosis of MIBC were compared with the original VI-RADS using McNemar test. Pathologic diagnosis was used as the reference standard.
RESULTS: PTE was present in 70-81% (25/36-29/36) of MIBC and absent in 92-98% (54/59-58/59) of non-MIBC. For all readers, the PTE was significantly more frequent (p < 0.001) in the MIBC group than the NMIBC group. The sensitivities of modified VI-RADS (75.0-86.1%) were significantly higher than those of original VI-RADS (41.7-55.6%) (p = 0.002-0.008). The specificity of modified VI-RADS (91.5-98.3%) were not statistically different from original VI-RADS (98.3-100%).
CONCLUSIONS: In conclusion, PTE is a highly specific finding for MIBC. modified VI-RADS incorporating PTE increases sensitivity for MIBC.
引用
- Takeuchi M, Higaki A, Kojima Y, et al. Diagnostic significance of peritumoral enhancement in distinguishing between muscle-invasive and non-muscle-invasive bladder cancer. Abdom Radiol (NY). 2024. PMID: 39472381. doi:10.1007/s00261-024-04658-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。